Dopaminergic mechanisms in patients with extrapyramidal disease

Adv Neurol. 1975:9:359-66.
No abstract available

Publication types

  • Comparative Study

MeSH terms

  • Animals
  • Biogenic Amines / metabolism
  • Brain / metabolism
  • Caffeine / administration & dosage
  • Clonidine / adverse effects
  • Dopamine
  • Drug Evaluation
  • Drug Therapy, Combination
  • Homovanillic Acid / cerebrospinal fluid
  • Humans
  • Hydroxyindoleacetic Acid / cerebrospinal fluid
  • Levodopa / therapeutic use
  • Parasympatholytics / administration & dosage
  • Parkinson Disease / drug therapy*
  • Parkinson Disease / metabolism
  • Piperazines / therapeutic use*
  • Piribedil / administration & dosage
  • Piribedil / pharmacology
  • Piribedil / therapeutic use*
  • Pituitary Gland, Anterior / metabolism
  • Prolactin / metabolism
  • Rats
  • Receptors, Drug
  • Stimulation, Chemical

Substances

  • Biogenic Amines
  • Parasympatholytics
  • Piperazines
  • Receptors, Drug
  • Caffeine
  • Levodopa
  • Hydroxyindoleacetic Acid
  • Prolactin
  • Piribedil
  • Clonidine
  • Dopamine
  • Homovanillic Acid